Skip to main content

Vaccines and Public Health Measures to Prepare for Future Pandemics

As Congress considers legislation to prevent and prepare for future pandemics, experts from The Duke Human Vaccine Institute (DHVI), Duke University Health System, and Duke-Margolis Center for Health Policy share their thoughts on what should be included in the package in a webinar at 2 p.m. today (Monday).

The event’s panelists include Tom Denny and Tony Moody of DHVI; Christina Silcox, a Duke Margolis Center fellow;  and School of Medicine Dean Mary Klotman.

In a short period of time, the world has gone through an unbelievable process of acknowledging, responding and acclimating to a global pandemic. Now Congress is working on bipartisan legislation to strengthen the nation’s public health infrastructure and outlines its next round of supplemental pandemic aid.

Vaccines are one of the most critical public health investments and the Duke Human Vaccine Institute (DHVI) has been a global leader in vaccine research since the 1980s, addressing global health issues such as HIV/AIDS, tuberculosis, influenza and zika. DHVI has recently been awarded a grant to develop the next-generation of pan-coronavirus vaccines.

In this conversation, Duke experts will discuss the importance of federal investment in research, translation of research to policy, the impacts they already see from their work, and additional recommendations to bolster our nation’s public health and medical preparedness and response systems.

Registration for the webinar is required. More about the event can be found on this LinkedIn page.